fulvestrant has been researched along with atrial natriuretic factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonz, AW; Ertl, G; Fritzemeier, KH; Hegele-Hartung, C; Hu, K; Jazbutyte, V; Muck, J; Nahrendorf, M; Neyses, L; Nordbeck, P; Pelzer, T; Segerer, S | 1 |
| Danalache, B; Gangal, M; Gutkowska, J; Jankowski, M; Wang, D | 1 |
2 other study(ies) available for fulvestrant and atrial natriuretic factor
| Article | Year |
|---|---|
The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Gene Expression; Hemodynamics; Hypertension; In Vitro Techniques; Magnetic Resonance Imaging; Models, Animal; Myocardium; Myosin Heavy Chains; Organ Size; Ovariectomy; Papillary Muscles; Random Allocation; Rats; Rats, Inbred SHR; Tamoxifen; Ventricular Myosins | 2005 |
Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fibrosis; Fulvestrant; Genistein; Hypertension; Myocardial Contraction; Myocardium; Natriuretic Peptide, Brain; Ovariectomy; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Oxytocin; RNA, Messenger; Vasotocin; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2010 |